SAB Biotherapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has SAB Biotherapeutics's balance sheet done over the years? Its assets were worth $83,941,253 last year, which is more than in the previous period. 32% of SAB Biotherapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $26,641,812, which means an increase by 34% compared compared to last year.

Debt to Assets

SAB Biotherapeutics, Inc. (NASDAQ:SABSW): Debt to assets
2019 18003555 20.30M 112.81%
2020 56537933 17.53M 31.01%
2021 79369220 40.81M 51.43%
2022 50904927 19.84M 38.99%
2023 83941253 26.64M 31.74%

SABSW Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
56.56M15.04M33.20M12.61M6.34M
Short term investments
00000
Net receivables
05.55M8.01M20.56M2.81M
Inventory
00000
Other current assets
2.34M1.49M7.20M1.27M0
Total current assets
58.90M22.09M48.42M34.45M9.28M
Non-current assets:
Property, Plant and Equipment
24.68M28.33M30.94M22.08M8.71M
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
350.23K467.69K000
Total non-current assets
25.03M28.80M30.94M22.08M8.71M
Total assets
83.94M50.90M79.36M56.53M18.00M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.32M0100K100K0
Short term debt
2.65M1.39M1.32M1.65M1.94M
Total current liabilities
10.81M14.99M24.68M11.06M4.61M
Non-current liabilities:
Long term debt
4.05M4.53M5.41M6.46M5.69M
Deferred tax
00000
Other non-current liabilities
11.77M320.93K10.72M09.99M
Total non-current liabilities
15.82M4.85M16.13M6.46M15.69M
Total liabilities
26.64M19.84M40.81M17.53M20.30M
Data sourceData sourceData sourceData source